Scatec ASA
Scatec ASA: Approval of Base Prospectus
Scatec ASA: Approval of Base Prospectus
Oslo 02 June 2025: The Financial Supervisory Authority of Norway has on 30 May 2025 approved the Base Prospectus with appendices prepared by Scatec ASA (the Company) in connection with the listing on the Oslo Stock Exchange of the Company’s NOK 1,250 million senior unsecured green bond issued on 05 February 2025, with maturity in February 2029 (with ISIN: NO0013476101).
The Base Prospectus is attached and published on the Company’s website: https://scatec.com/investor/investor-overview/
For further information, please contact:
Cecilie Engh Sætre, SVP Corporate Finance & Treasury
Cecilie.Engh.Satre@scatec.com
+47 970 68 181
About Scatec
Scatec is a leading renewable energy solutions provider, accelerating access to reliable and affordable clean energy emerging markets. As a long-term player, we develop, build, own, and operate renewable energy plants, with 6.2 GW in operation and under construction across five continents today. We are committed to grow our renewable energy capacity, delivered by our passionate employees and partners who are driven by a common vision of ‘Improving our Future’. Scatec is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol ‘SCATC’. To learn more, visit www.scatec.com or connect with us on LinkedIn.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd3.6.2025 23:30:00 CEST | Press release
Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
DBV Technologies S.A.3.6.2025 22:30:00 CEST | Press release
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Orion Oyj3.6.2025 22:30:00 CEST | Press release
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
Merus N.V.3.6.2025 22:05:00 CEST | Press release
Merus N.V. Announces Proposed Public Offering of Common Shares
Eurocommercial Properties N.V.3.6.2025 17:48:25 CEST | Press release
EUROCOMMERCIAL PROPERTIES N.V.: TOTAL 2024 DIVIDEND DECLARED
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom